Published in Genomics on July 01, 1996
Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest (2003) 2.04
Adeno-associated virus site-specifically integrates into a muscle-specific DNA region. Proc Natl Acad Sci U S A (2000) 1.13
Search for intracranial aneurysm susceptibility gene(s) using Finnish families. BMC Med Genet (2002) 1.02
Transcriptional regulation of PRPF31 gene expression by MSR1 repeat elements causes incomplete penetrance in retinitis pigmentosa. Sci Rep (2016) 0.86
Requirement of transcription factor NFAT in developing atrial myocardium. J Cell Biol (2003) 0.85
High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians. BMC Med Genet (2012) 0.80
Possible regulatory roles of promoter g-quadruplexes in cardiac function-related genes - human TnIc as a model. PLoS One (2013) 0.76
Identification of rare variants in TNNI3 with atrial fibrillation in a Chinese GeneID population. Mol Genet Genomics (2015) 0.76
Genetic variation in exon 5 of troponin - I gene in hypertrophic cardiomyopathy cases. Indian J Hum Genet (2007) 0.76
Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation. Korean Circ J (2017) 0.75
Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells. Int J Clin Exp Pathol (2014) 0.75
Cloning of a newly identified heart-specific troponin I isoform, which lacks the troponin T binding portion, using the yeast hybrid system. Exp Clin Cardiol (2006) 0.75
A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (1988) 9.07
The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation. J Epidemiol Community Health (1988) 3.35
Asymmetric redirection of flow through the heart. Nature (2000) 2.99
The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis (1994) 2.57
Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation (1994) 2.21
5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res (1990) 2.16
Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol (2001) 2.15
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet (1990) 2.04
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation (1998) 1.79
Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol (1993) 1.77
Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur Heart J (1999) 1.60
Successful double-lung transplantation with direct bronchial artery revascularization. Ann Thorac Surg (1993) 1.60
Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation (2001) 1.56
Identification of novel, cardiac-restricted transcription factors binding to a CACC-box within the human cardiac troponin I promoter. Cardiovasc Res (2001) 1.55
Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet (1995) 1.55
High molecular weight kininogen deficiency: a patient who underwent cardiac surgery. Thromb Haemost (2001) 1.52
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation (2001) 1.52
Specialist surgery in the developing world: luxury or necessity? Anaesthesia (2007) 1.52
Anatomy of the coronary arteries in transposition of the great arteries and methods for their transfer in anatomical correction. Thorax (1978) 1.51
Anatomy of the muscular subpulmonary infundibulum with regard to the Ross procedure. Ann Thorac Surg (2000) 1.51
Endothelial function of human gastroepiploic artery. Implications for its use as a bypass graft. J Thorac Cardiovasc Surg (1991) 1.50
Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation (2001) 1.46
Left atrial tamponade. Thorax (1966) 1.45
Heterotopic cardiac transplantation in infants and children. J Thorac Cardiovasc Surg (1997) 1.43
Immunocytochemical changes suggestive of damage to endothelial cells during rejection of human cardiac allografts. Transplantation (1990) 1.43
Valve interstitial cells induce donor-specific T-cell anergy. J Thorac Cardiovasc Surg (2001) 1.43
Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene (1999) 1.42
Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol (1997) 1.42
Development of an opiate-based anaesthetic technique for use in dogs with cardiomyopathy. Vet Rec (1991) 1.42
Naive neutrophils and xenotransplantation. Lancet (1996) 1.41
Two-stage operation for anatomical correction of transposition of the great arteries with intact interventricular septum. Lancet (1977) 1.41
Retransplantation in heart-lung recipients with obliterative bronchiolitis. J Thorac Cardiovasc Surg (1994) 1.39
Magnetic resonance characterization of pulmonary arterial blood flow after single lung transplantation. J Thorac Cardiovasc Surg (1991) 1.38
Gianturco self-expanding metallic stents in treatment of tracheobronchial stenosis after single lung and heart and lung transplantation. Eur J Cardiothorac Surg (1991) 1.38
Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol (1992) 1.38
End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36
Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest (1996) 1.35
Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol (1999) 1.35
Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J (1991) 1.35
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol (1998) 1.34
Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis (1992) 1.33
A new technique for replacement of the mitral valve by a semilur valve homograft. J Thorac Cardiovasc Surg (1969) 1.30
Hematoma of the interatrial septum with heart block secondary to dissecting aneurysm of the aorta. A clinicopathologic entity. Circulation (1972) 1.26
Anatomical correction of complete transposition of the great arteries and ventricular septal defect in infancy. Br Med J (1976) 1.25
Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol (1997) 1.24
Opening and closing characteristics of the aortic valve after different types of valve-preserving surgery. Circulation (1999) 1.24
Candida endocarditis after heart surgery. Thorax (1968) 1.23
Early and long-term results of a valve-sparing operation for Marfan syndrome. Circulation (1999) 1.23
The myosin alkali light chain proteins and their genes. Biochem J (1985) 1.22
Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation (1988) 1.19
Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation (1996) 1.18
Aortic homograft replacement of the mitral valve in sickle cell trait. J Thorac Cardiovasc Surg (1970) 1.18
Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res (1993) 1.18
Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant (2004) 1.17
Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest (1993) 1.17
The myosin alkali light chains of mouse ventricular and slow skeletal muscle are indistinguishable and are encoded by the same gene. J Biol Chem (1985) 1.16
Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res (1990) 1.16
Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation (2001) 1.15
Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr (1990) 1.15
Cardiovascular effects of intravenous salbutamol after open heart operations. Lancet (1973) 1.15
Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation (2000) 1.14
Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus 'beating heart' surgery. Eur Heart J (2000) 1.14
Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation (2000) 1.13
Aneurysm of the ascending aorta presenting with pulmonary stenosis. Thorax (1966) 1.13
Chronic haemolysis following insertion of ball valve prostheses. Br Heart J (1968) 1.13
Outcome of non-elective coronary artery bypass grafting without cardio-pulmonary bypass. Eur J Cardiothorac Surg (2001) 1.13
Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus. Transplantation (2000) 1.12
Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol (2000) 1.12
Left ventricular contractility and contractile reserve in humans after cardiac transplantation. Circulation (1985) 1.11
Developmental expression of troponin I isoforms in fetal human heart. FEBS Lett (1991) 1.10
Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation (2000) 1.10
Late endothelial function of free and pedicled internal mammary artery grafts. J Thorac Cardiovasc Surg (1995) 1.10
The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res (2001) 1.10
Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation (1992) 1.09
Dehiscence of infected aortocoronary vein graft suture lines. Cause of late pseudoaneurysm of ascending aorta. Br Heart J (1983) 1.09
Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg (1996) 1.08
Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation (2000) 1.08
Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J Heart Valve Dis (2000) 1.07
Assessment of left ventricular contractile state after anatomic correction of transposition of the great arteries. Circulation (1984) 1.07
Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. Am J Respir Cell Mol Biol (2001) 1.07
Human cardiac troponin T: identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q. Genomics (1994) 1.06
Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. Br Heart J (1994) 1.06
Endarterectomy of the left coronary system. Analysis of a 10 year experience. J Thorac Cardiovasc Surg (1985) 1.06
Congenital pericardial defects. Thorax (1968) 1.05
PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. Eur Respir J (2004) 1.05
Expression of homeobox genes Msx-1 (Hox-7) and Msx-2 (Hox-8) during cardiac development in the chick. Dev Dyn (1993) 1.04
Homograft replacement of the aortic valve. A critical review. Prog Cardiovasc Dis (1969) 1.04